The levels of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and interleukin 1 beta (IL-1β), which drive chronic inflammation in plasma and lymph nodes, remain elevated from early infection stages and persist even in ART-treated individuals. This evidence concerns the gene IL6 and infection.